RUBY
Rubius Therapeutics, Inc.
Set alert
0.06 USD 0.00 0.00%
0.055 Day range 0.057
0.0032 52-week range 0.3763
- Open
- 0.0555
- Prev close
- 0.057
- Mkt cap
- 0
- Vol
- 755.86K
- Avg vol
- 99.53K
- EPS
- -1.99
- P/E
- -0.03
- Div yield
- 0.00%
More statistics
- Low
- 0.055
- High
- 0.057
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 3, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
Financial health
Altman Z-Score
-81.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.1×
FY 2016 5y median -4.5× FY 2022
P/S 0.0×
FY 2016 5y median 0.0× FY 2022
P/B 1.0×
FY 2016 5y median 2.8× FY 2022
P/FCF -0.1×
FY 2016 5y median -4.9× FY 2022
EV/EBITDA -0.0×
FY 2016 5y median -4.1× FY 2022
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2022
FCF Yield -983.6%
FY 2016 5y median -20.2% FY 2022
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2022
ROE -1525.8%
FY 2016 5y median -105.6% FY 2022
ROIC -1099.4%
FY 2016 5y median -62.1% FY 2022
ROA -1000.7%
FY 2016 5y median -58.3% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2022
Operating Income 8.3%
FY 2016 FY 2022
EPS (diluted) -19.1%
FY 2016 FY 2022
Free Cash Flow -4.5%
FY 2016 FY 2022
Financial Health
Current Ratio 2.5×
FY 2016 5y median 6.6× FY 2022
Quick Ratio 2.5×
FY 2016 5y median 6.6× FY 2022
Debt / Equity 0.1×
FY 2016 5y median 0.4× FY 2022
Net Debt / EBITDA 0.1×
FY 2016 5y median 0.1× FY 2022
Interest Coverage -46.2×
FY 2016 5y median -46.2× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31